Skip to main content

Navigation group

Type at least 3 characters
1,766 articles

Articles

Original Research

Published on 24 Aug 2023

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile

in Infectious Diseases: Epidemiology and Prevention

  • Diego A. Díaz-Dinamarca
  • Pablo Díaz
  • Gisselle Barra
  • Rodrigo Puentes
  • Loredana Arata
  • Jonnathan Grossolli
  • Boris Riveros-Rodriguez
  • Luis Ardiles
  • Julio Santelises
  • Valeria Vasquez-Saez
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
Frontiers in Public Health
doi 10.3389/fpubh.2023.1229045
  • 2,270 views
  • 1 citation